$58.3 Million is the total value of SOPHROSYNE CAPITAL LLC's 34 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GTLS | Exit | CHART INDS INC | $0 | – | -875 | -100.0% | -0.05% | – |
| GLOG | Exit | GASLOG LTD | $0 | – | -2,000 | -100.0% | -0.06% | – |
| LNG | Exit | CHENIERE ENERGY INC | $0 | – | -1,400 | -100.0% | -0.15% | – |
| SLB | Exit | SCHLUMBERGER LTD | $0 | – | -1,200 | -100.0% | -0.16% | – |
| GENC | Exit | GENCOR INDS INC | $0 | – | -12,150 | -100.0% | -0.18% | – |
| CLRBW | Exit | CELLECTAR BIOSCIENCES INC*w exp 08/19/201 | $0 | – | -151,299 | -100.0% | -0.18% | – |
| MCUR | Exit | MACROCURE LTD | $0 | – | -20,000 | -100.0% | -0.22% | – |
| CEMI | Exit | CHEMBIO DIAGNOSTICS INC | $0 | – | -103,400 | -100.0% | -0.63% | – |
| REFR | Exit | RESEARCH FRONTIERS INC | $0 | – | -81,629 | -100.0% | -0.64% | – |
| CLRB | Exit | CELLECTAR BIOSCIENCES INC | $0 | – | -142,100 | -100.0% | -0.68% | – |
| P | Exit | PANDORA MEDIA INC | $0 | – | -41,100 | -100.0% | -1.13% | – |
| PIP | Exit | PHARMATHENE INC | $0 | – | -500,000 | -100.0% | -1.39% | – |
| CYNO | Exit | CYNOSURE INCcl a | $0 | – | -89,700 | -100.0% | -3.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-04-20
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PURECYCLE CORP | 10 | Q3 2015 | 25.2% |
| MEETME INC | 9 | Q2 2015 | 8.3% |
| CADIZ INC | 9 | Q3 2015 | 6.6% |
| ENVIVIO INC | 9 | Q2 2015 | 3.3% |
| LIMONEIRA CO | 9 | Q3 2015 | 0.6% |
| ZELTIQ AESTHETICS INC | 8 | Q1 2015 | 10.3% |
| MICROSTRATEGY INC | 8 | Q1 2015 | 8.5% |
| BIODELIVERY SCIENCES INTL IN | 8 | Q1 2015 | 5.3% |
| PROCERA NETWORKS INC | 8 | Q1 2015 | 3.7% |
| AXOGEN INC | 8 | Q2 2015 | 5.6% |
View SOPHROSYNE CAPITAL LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ASPEN GROUP, INC. | February 12, 2016 | 1,690,490 | 1.3% |
| MeetMe, Inc. | April 07, 2014 | 1,855,835 | 4.8% |
| Venaxis, Inc.Sold out | January 29, 2014 | 0 | 0.0% |
| VENTRUS BIOSCIENCES INCSold out | January 29, 2014 | 0 | 0.0% |
| S&W Seed Co | October 01, 2013 | 554,213 | 4.8% |
| CardioNet, Inc. | September 23, 2013 | 1,038,518 | 4.1% |
| SMITH MICRO SOFTWARE INC | August 22, 2013 | 1,827,998 | 4.9% |
| Coastal Contacts Inc | June 14, 2013 | 1,100,263 | 3.4% |
| BIODELIVERY SCIENCES INTERNATIONAL INC | April 05, 2013 | 1,595,441 | 4.2% |
| Stereotaxis, Inc.Sold out | April 05, 2013 | 0 | 0.0% |
View SOPHROSYNE CAPITAL LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2016-02-12 |
| 13F-HR | 2015-11-13 |
| 13F-HR | 2015-08-14 |
| 13F-HR | 2015-04-20 |
| 13F-HR | 2015-01-26 |
| SC 13G/A | 2015-01-26 |
| 13F-HR | 2014-11-14 |
| SC 13G/A | 2014-09-10 |
| 13F-HR | 2014-08-14 |
| 13F-HR | 2014-05-14 |
View SOPHROSYNE CAPITAL LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.